P2Y12 Inhibitor Monotherapy or Dual Antiplatelet Therapy After Complex Percutaneous Coronary Interventions

Felice Gragnano(Ospedale Sant'Anna), Marco Valgimigli(University of Bern), Byeong‐Keuk Kim(Ewha Womans University), C. Michael Gibson(Brigham and Women's Hospital), Yangsoo Jang(Yonsei University), Sung‐Jin Hong(Inje University Sanggye Paik Hospital), Yunpeng Zhu(Shanghai Jiao Tong University), Roxana Mehran(Icahn School of Medicine at Mount Sinai), Dominick J. Angiolillo(Jacksonville University), Young Bin Song(Samsung Medical Center), Dik Heg, Stephan Windecker, George Dangas, Shamir R. Mehta(Population Health Research Institute), Pascal Vranckx(Jessa Hospital), Patrick W. Serruys(Ollscoil na Gaillimhe – University of Galway), Hirotoshi Watanabe(Kyoto University), Hyeon‐Cheol Gwon(Samsung Medical Center), Usman Baber(Icahn School of Medicine at Mount Sinai), Joo‐Yong Hahn(Samsung Medical Center), Anna Franzone(University Hospital of Bern), Mattia Branca, Takeshi Kimura(Kyoto University), Qiang Zhao(Ruijin Hospital), Eugène McFadden(Skadden Arps Slate Meagher & Flom), Paolo Calabrò(University of Campania "Luigi Vanvitelli")
Journal of the American College of Cardiology
February 1, 2023
Cited by 119


Related Papers